Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer

Barbara Melosky1

  • 1Medical Oncology, British Columbia Cancer Agency - Vancouver Centre , Vancouver, BC , Canada.

Frontiers in Oncology
|October 18, 2014
PubMed

Insights

New treatments for metastatic non-squamous non-small cell lung cancer offer personalized care and improved survival. This paper presents a simplified treatment algorithm for these patients.

Area of Science:

  • Oncology
  • Medical Genetics

Background:

  • Advances in understanding molecular pathways and large-scale clinical trials are transforming lung cancer treatment.
  • The management of metastatic non-squamous non-small cell lung cancer (NSCLC) is evolving rapidly.

Purpose of the Study:

  • To present a simplified treatment algorithm for metastatic non-squamous NSCLC.
  • To guide clinicians in the personalized management of advanced lung cancer.

Main Methods:

  • Review of recent molecular pathway research in NSCLC.
  • Analysis of outcomes from major clinical trials in metastatic lung cancer.

Main Results:

  • Personalized and more efficacious treatment strategies are emerging.
  • Increased survival rates are observed in specific patient cohorts.

Conclusions:

  • A simplified algorithm can aid in the effective management of metastatic non-squamous NSCLC.
  • Personalized medicine approaches are improving patient prognosis.